Abstract: An apparatus for estimating bio-information according to an embodiment includes: a sensor that measures a pulse wave signal from an object and contact pressure of the object; and a processor that obtains an oscillometric envelope based on an amplitude of the pulse wave signal and the contact pressure, and estimates bio-information based on a center of mass of a phase of contact pressure of the obtained oscillometric envelope.

Abstract: Methods and apparatus are disclosed relating to the stimulating of tissue including nerve tissue based on combinations of capacitors and resistors. Application and removal of voltage to an electrical circuit is taught as part of a method of creating voltage waveforms for nerve and other tissue with such waveforms creating neural signals.

Abstract: The present invention relates to a pharmaceutical composition for prevention or treatment of a muscular disease, the composition comprising dimenhydrinate, harmol and/or calcium pantothenate as active ingredients. Application of dimenhydrinate, harmol, and calcium pantothenate individually has an effect of promoting myoblast proliferation and differentiation. In particular, the combination thereof has the effect of synergistically increasing the effect of promoting myoblast proliferation and differentiation. Thus, dimenhydrinate, harmol and/or calcium pantothenate may be usefully used alone or in combination for the prevention or treatment of muscular diseases, in particular sarcopenia.

Abstract: An image sensor includes a pixel array of pixels arranged in one or more rows and one or more columns, the pixel array configured to generate an image based on light being incident on one or more pixels of the pixel array. The image sensor includes pixel load circuitry connected to one column of pixels and including transistors serially connected to each other. The image sensor includes switches connected in parallel to separate, respective nodes between adjacent transistors. The image sensor includes image sensor processing circuitry configured to receive, from image processor circuitry, gain information indicating an intensity of light concurrently with an image being generated by the image sensor, and control at least one switch of the plurality of switches to be turned on/off to change an electrical path of a current that passes through the pixel load circuitry, based on the gain information.

Abstract: The present invention relates to nucleic acid molecules that simultaneously inhibit the expression of AR gene and mTOR gene, wherein the double-stranded siRNA and shRNA of the present invention were designed to simultaneously inhibit the expression of the AR gene and the mTOR gene which are associated with cancer. The double-stranded siRNA and shRNA of the present invention promote cancer cell death and synergistically enhance cancer cell death in combination with an anticancer agent, so that various types of cancer may be effectively prevented and treated.

Abstract: Provided is a pharmaceutical composition for preventing or treating neuronal diseases comprising, as an active ingredient, an exon 2-deleted AIMP2 variant (AIMP2-DX2) gene or a vector comprising the gene, and a method for treating neuronal diseases in animals other than humans, comprising administering the same to a subject in need of treatment. The pharmaceutical composition comprising, as an active ingredient, a AIMP2-DX2 gene or a vector comprising the gene has the effects of apoptosis inhibition, dyskinesia amelioration and oxidative stress inhibition and thus can be widely used for preventing and treating neuronal diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Abstract: A display device includes: a display panel including a display area and a non-display area that extends from an end of the display area and is bent toward the display area; and a passivation film including a first film portion that is attached to a surface of the non-display area and is bent toward the display area, and a second film portion that is attached to a surface of the display area, and a modulus of the first film portion is lower than a modulus of the second film portion.

Abstract: Methods and apparatus are disclosed relating to the stimulating of tissue including nerve tissue based on combinations of capacitors and resistors. Application and removal of voltage to an electrical circuit is taught as part of a method of creating voltage waveforms for nerve and other tissue with such waveforms creating neural signals. The electrical circuits taught may, include a first electrical node grounded through a first resistor; a second electrical node grounded through a second resistor; a first capacitor connected to both the first electrical node and the second electrical node; a second capacitor separating the second electrical node from a biological grounding point and direct current sources connected to the two nodes.

Abstract: Provided is a binder composition including polylysine and at least one reducing sugar or a derivative thereof, wherein the polylysine has, in a 1H NMR spectrum thereof, a first peak at 3.2 ppm to 3.4 ppm and a second peak at 3.8 ppm to 4.0 ppm, wherein a ratio (A:B) of an area of the first peak (A) to an area of the second peak (B) is 70:30 to 98:2.

Abstract: A blood pressure measuring apparatus includes a pulse wave sensor configured to detect a pulse wave signal of an object, a pressure sensor configured to detect a contact pressure signal corresponding to a contact pressure between the object and the pulse wave sensor, and a processor configured to generate a pulse wave image based on the detected pulse wave signal of the object, generate a contact pressure image based on the detected contact pressure signal corresponding to the contact pressure between the object and the pressure sensor, and estimate a blood pressure of the object based on the generated pulse wave image, the generated contact pressure image, and a blood pressure estimation model.

Abstract: Various examples of methods and systems are provided for increasing productivity of one or more photosynthetic cultures via self-powered energy output systems. In one example, a system includes a waterproof casing and an energy output module enclosed within the waterproof casing. The waterproof casing is configured to be neutrally buoyant in an enclosure comprising the one or more photosynthetic cultures. In another example, a method includes placing a self-powered energy output system within an enclosure, the self-powered energy output system being neutrally buoyant within the enclosure. The method further includes causing turbulence within the enclosure, and the self-powered energy output system harvests energy to power the self-powered energy output system via the turbulence within the enclosure.

Abstract: The present invention relates to a pharmaceutical composition containing broussochalcone A as an active ingredient for prevention or treatment of inflammatory bowel disease. The pharmaceutical composition containing broussochalcone A as an active ingredient for prevention or treatment of inflammatory bowel disease of the present invention suppresses inflammation to ameliorate symptoms of weight loss, reduction in bowel length, diarrhea, and hemafecia, which result from inflammatory bowel disease, and has no side effects occurring in an existing drug medicine, and thus can be effectively used in the treatment of inflammatory bowel disease.

Abstract: A biometric authentication system and method are provided that are based on PPG signals acquired using non-invasive methods, such as pulse oximeter, for example. Compared to the other biometric authentication approaches, PPG signals are relatively easy to acquire, relatively difficult to duplicate, and can be adaptively updated, which are qualities that make them well suited for biometric authentication. However, PPG signals are often corrupted by motion artifacts (MAs) due to the unique measurement technique, i.e., placement of a sensor close to the skin. The system and method employ an MA removal algorithm to remove or mitigate MAs to provide a PPG-based biometric authentication solution that is robust and that can be implemented relatively easily and cost effectively.

Abstract: An electro-acupuncture (EA) system and method for performing EA on a patient are provided. The EA system comprises a wearable neurostimulator device, at least a first pair of electrically-conductive acupuncture needles and a system controller. The wearable neurostimulator device comprises a casing, an EA circuit mechanically coupled to the casing, and an attachment device mechanically coupled to the casing and adapted to removably secure the wearable neurostimulator device to the patient. The first pair of electrically-conductive acupuncture needles is mechanically coupled to the casing and electrically coupled to the EA circuit. The system controller is in communication with the EA circuit of the wearable neurostimulator device via a communication link and controls the EA circuit to cause the EA circuit to output an output voltage selected by the system controller at a frequency selected by the system controller.

Abstract: Various examples of methods and systems are provided for increasing productivity of one or more photosynthetic cultures via self-powered light systems. In one example, a system includes a waterproof casing and a light module enclosed within the waterproof casing. The waterproof casing is configured to be neutrally buoyant in a culture tank comprising the one or more photosynthetic cultures. In another example, a method includes placing a self-powered light system within a culture tank, the self-powered light system being neutrally buoyant within the culture tank. The method further includes causing turbulence of water within the culture tank, and the self-powered light system harvests energy to power a light of the self-powered light system via the turbulence of the water within the culture tank.

Abstract: A display device includes: a display panel including a display area and a non-display area that extends from an end of the display area and is bent toward the display area; and a passivation film including a first film portion that is attached to a surface of the non-display area and is bent toward the display area, and a second film portion that is attached to a surface of the display area, and a modulus of the first film portion is lower than a modulus of the second film portion.

Abstract: The present invention relates to a method of manufacturing an orally disintegrating dosage form which masks a bitter or unpleasant taste. A composition including a ratio of excipients and a coated active substance prevents a coating layer on the active substance from being destroyed during manufacture.

Abstract: A message service providing method for a message service linked to a search service and a message server and a user terminal for performing the method are disclosed. The message service providing method includes identifying an instant message input through a message input box of a message application switching from a chat mode to a search mode or a suggested search word selected from suggested search words in a suggested search word list displayed in conjunction with the message input box, transferring, to a search server, a search request for a search word including a whole or a portion of the identified instant message or suggested search word in response to a user input provided to the message application, receiving search result data derived through the search word.

Abstract: A touch-panel liquid-crystal display device in one embodiment includes a metal line formed on a thin-film transistor array substrate, a gap column spacer and a push column spacer on a portion of a color filter array substrate that corresponds to an intersection of gate and data lines of the thin-film transistor array substrate, and a liquid-crystal layer between the thin-film transistor array substrate and the color filter array substrate. The gap column spacer and the push column spacer have the same height and the gap column spacer is located on the metal line, which facilitates an exposure process, minimizes generation of foreign substances when printing an alignment layer, and enables adjustment of the optimum amount of liquid crystals when liquid-crystal dotting is performed. The push column spacer is located on the metal line when the device can be pushed or bent by external force, and thus increases panel rigidity.

Abstract: The present invention relates to a composition for photodynamic therapy of cancer diseases using a gene expressing a fluorescent protein and a photosensitizer, and a photodynamic therapy method using the same. More specifically, the present invention provides a composition for photodynamic therapy capable of selectively killing cancer cells only without affecting normal cells by treating the cancer cells, into which various fluorescent proteins have been introduced, with a photosensitizer and then irradiating a light source to the cancer cells, and a photodynamic therapy method using the same.